NEW YORK (GenomeWeb) —EKF Molecular Diagnostics said today that its collaboration with circulating tumor cell firm Gilupi in the area of CTC DNA enrichment has yielded positive results.

EKF said that by using its PointMan DNA enrichment technology with Gilupi's CellCollector platform, scientists from the company were able to detect gene mutations from three or fewer cells isolated in a model in vitro system and from the blood of lung cancer patients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.